The interaction between captured human thrombin and antithrombin studied by surface plasmon resonance, and the effect of melagatran

Spectroscopy

Volumn 16, Issue 3-4, 2002, Pages 257-270

  Elg, Susanne ^a   Deinum, Johanna ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; ANTIBODIES; PROTEINS; REACTION KINETICS; STOICHIOMETRY; SURFACE PLASMON RESONANCE;

ACTIVE-SITE INHIBITORS;

SPECTROSCOPIC ANALYSIS;

AMINE; ANTIBODY; ANTITHROMBIN; HIRUDIN; MELAGATRAN; THROMBIN;

ARTICLE; BINDING AFFINITY; DRUG EFFECT; HUMAN; KINETICS; MOLECULAR WEIGHT; PROTEIN PROTEIN INTERACTION; STOICHIOMETRY; SURFACE PLASMON RESONANCE;

EID: 0036965931     PISSN: 07124813     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/673974     Document Type: Article

References (24)

1. T. Nilsson, A. Sjoling-Ericksson, J. Deinum, The mechanism of binding of low-molecular-weight active site inhibitors to human alpha-thrombin, J. Enzym. Inhib. 13 (1998), 11-29.
2. R. Karlsson, M. Kullman-Magnusson, M. D. Hamalainen, A. Remaeus, K. Andersson, P. Borg, E. Gyzander and J. Deinum, Biosensor analysis of drug-target interactions: Direct and competitive binding assays for investigation of interactions between thrombin and thrombin inhibitors, Anal. Biochem. 278 (2000), 1-13.
3. J. Deinum, L. Gustavsson, E. Gyzander, M. Kullman-Magnusson, A. Edstrom and R. Karlsson, A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin, combining biosensor technology, stopped-flow spectrophotometry, and microcalorimetry, Anal. Biochem. 300 (2002), 152-162.
4. M. Elg, D. Gustafsson and J. Deinum, The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis, Thrombosis & Haemostasis 78 (1997), 1286-1292.
5. D. Gustafsson, T. Antonsson, R. Bylund, U. Eriksson, E. Gyzander, I. Nilsson, M. Elg, C. Mattsson, J. Deinum, S. Pehrsson, O. Karlsson, A. Nilsson and H. Sorensen, Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes, Thrombosis & Haemostasis 79 (1998), 110-118.
6. R. Jordan, D. Beeler and R. Rosenberg, Fractionation of low molecular weight species and their interaction with antithrombin, J. Biol. Chem. 254 (1979), 2902-2908.
7. S. Olson and I. Bjork, Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects, J. Biol. Chem. 266 (1991), 6353-6364.
8. J.C. Whisstock, N.P. Pike, L. Jin, R. Skinner, X.Y. Pei, R.W. Carrell and A.M. Lesk, Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin, J. Molecular Biology 301 (2000), 1287-1305.
9. T. Laurent, A. Tengblad, L. Thunberg, M. Höök and U. Lindahl, The molecular-weight-dependence of the anticoagulant activity of heparin, Biochem. J. 175 (1978), 691-696.
10. E. Stenberg, B. Persson, H. Roos and C. Urbanniczky, Quantitative detrmination of surface concentration of protein with surface plasmon resonance by using radiolabelled proteins, J. Colloid Interface Sci. 143 (1991), 513-526.
11. P.R. Edwards and R.J. Leatherbarrow, Determination of association rate constants by an optical biosensor using initial rate analysis, Anal. Biochem. 246 (1997), 1-6.
12. R. Leatherbarrow and P. Edwards, Analysis of molecular recognition using optical biosensors, Curr. Opin. Chem. Biol. 3 (1999), 544-547.
13. P. Björquist, M. Brohlin, J. Ehnebom, M. Ericsson, C. Kristiansen, G. Pohl and J. Deinum, Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator, Biochim. Biophys. Acta 1209 (1994), 191-202.
14. W. Bode and M.T. Stubbs, Spatial structure of thrombin as a guide to its multiple sites of interaction, Seminars in Thrombosis and Hemostasis 19 (1993), 321-333.
15. T. Myles, F.C. Church, H.C. Whinna, D. Monard and S.R. Stone, Role of thrombin anionbinding exosite-I in the formation of thrombin-serpin complexes, J. Biol. Chem. 273 (1998), 31 203-31 208.
16. G. Villanueva and I. Danishefsky, Conformational changes accompanying the binding of antithrombin III to thrombin, Biochemistry 18 (1979), 810-817.
17. J. Dawes, K. James and D.A. Lane, Conformational change in antithrombin induced by heparin, probed with a monoclonal antibody against the 1C/4B region, Biochemistry 33 (1994), 4375-4383.
18. A. Hijikata-Okunomiya, S. Okamoto and K. Wanaka, Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III, Thromb. Res. 59 (1990), 967-977.
19. Z.-R. Gan, Y. Li, Z. Chen, S.D. Lewis, J.A. Shafer, Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III, J. Biol. Chem. 269 (1994), 1301-1305.
20. S.T. Olson and J.D. Shore, Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by anti-thrombin III and identification of the step affected by heparin, J. Biol. Chem. 257 (1982), 14 891-14 895.
21. S.T. Olson and I. Bjork, Regulation of thrombin activity by antithrombin and heparin, Semin. Thromb. Hemost. 20 (1994), 373-409.
22. D.G. Myszka, X. He, M. Dembo, T.A. Morton and B. Goldstein, Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data, Biophys. J. 75 (1998), 583-594.
23. P. Schuck, Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors, Curr. Opin. Biotechnol. 8 (1997), 498-502.
24. H. Fuchs, M. Shifman and S. Pizzo, In vivo catabolism of α1-proteinase inhibitor, antithrombin III-thrombin and α2-macroglobulin-methylamine, Biochim. Biophys. Acta 716 (1982), 151-157.